Stay updated with breaking news from Prep Kits. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The growth of the genomics market is attributed to the increasing prevalence of chronic diseases, declining cost of sequencing procedures, and growing funding for genomics. However, the lack
/PRNewswire/ -- According to The Insight Partners study on "Genomics Market to 2027 – Global Analysis and Forecast – by Technology, Product and Sevice,...
Excessive inflammation is a characteristic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, particularly in patients that are hospitalized with coronavirus disease 2019 (COVID-19). Here, Hoepel et al. investigated how human antibodies specific to SARS-CoV-2 spike protein may contribute to exacerbated inflammation. The authors found that spike protein–specific antibodies from patients with COVID-19 who were hospitalized had altered glycosylation, with an enrichment in low-fucosylated antibodies. These antibodies were able to activate human macrophages in vitro to sec...
Posted on 138 Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced today the acquisition of Swift Biosciences, a pioneer in the development of Next-Generation Sequencing (NGS) library preparation genomics kits for academic, translational, and clinical research. IDT is a leader in developing and manufacturing nucleic acid products for academic and commercial research, agriculture, medical diagnostics, pharmaceutical development, and synthetic biology. Swift develops and commercializes NGS...
SARS-CoV-2 Real-Time RT-PCR Assay The PerkinElmer SARS-CoV-2 Real-Time RT-PCR assay is CE-IVD (in vitro diagnostic) marked and intended for qualitative detection of nucleic acid from the SARS-CoV-2 virus in human oropharyngeal swab, nasopharyngeal swab, and saliva specimens from individuals suspected of having COVID-19 or from asymptomatic carriers. The assay target two specific genomic regions of SARS-CoV-2: the nucleocapsid (N) gene and ORF1ab; so mutations in spike protein, as seen in the B.1.1.7 and B.1.351 coronavirus lineages, do not impact the safety and effectiveness of PerkinElmer's ...